Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The ExPlas Study
NCT05068830Phase 2Active, not recruiting
- Sponsor
- Norwegian University of Science and Technology
- Start
- Sep 2021
- Primary completion
- Mar 2027
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ExPlas in Alzheimer's disease (AD), sponsored by Norwegian University of Science and Technology. Started Sep 2021; status: active, not recruiting.
02
Drugs
ExPlas
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05068830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05068830.